Success Story: From Materials Science to Regenerative Medicine: NIW Approval for a Scientist from South Korea
Client’s Testimonial:
“The team is very knowledgeable and really knows what they are doing. I was impressed by the prompt responses and professionalism and felt heard when I gave the team feedback on their drafts, which were thorough and effective. I am so glad I went with Chen to get the petition approved with no RFE. Thank you so much for your help.”
On September 9th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist in the Field of Materials Science (Approval Notice).
General Field: Materials Science
Position at the Time of Case Filing: Scientist
Country of Origin: South Korea
State of Residence at the Time of Filing: California
Approval Notice Date: September 9th, 2026
Processing Time: 2 months, 18 days
Case Summary:
The client’s work demonstrated how advances in materials science could help address challenges far beyond the materials themselves. Holding a Ph.D. in materials science and engineering, the client specializes in biomaterials and proposed continuing the development of biodegradable materials and perfusable tissue platforms that supported stem cell growth and long-term tissue function. North America Immigration Law Group (Chen Immigration Law Associates) presented this endeavor as research with potential benefits for maternal health, biomedical innovation, and regenerative therapies in the United States.
The client had already established a strong research foundation before pursuing this next stage of work. The client's record included 6 peer-reviewed journal articles, published in respected materials science and biomaterials journals. These publications had accumulated 149 citations. The client had also been invited to evaluate the research of other scientists, completing at least 1 peer review for a scientific journal.
The petition demonstrated how independent researchers actively built upon the client’s findings. Outside studies had utilized this work to better understand how structural design and material dynamics enhanced the delivery and efficacy of biologically active components. These concrete examples established that the client's research provided foundational principles for scientists engineering advanced biomaterials with improved therapeutic and clinical functionality. This previous research had also received support from the U.S. Department of Energy and the National Institutes of Health, further documenting the recognized value of the work.
Looking forward, the client planned to translate this expertise into advanced biomaterials that closely replicated natural cellular environments. The client's ongoing work included developing specialized systems that supported complex tissue development and engineering advanced platforms for sustained biological function. NAILG directly connected these innovations to critical U.S. healthcare needs in regenerative medicine, demonstrating how these technologies improved complex clinical outcomes and advanced vital research in organ repair and replacement.
The approval supported the client’s continued pursuit of materials science research that bridged biomaterial design with practical biomedical applications, creating new possibilities for regenerative medicine and improved reproductive health.